Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma

BACKGROUND: Secondary lymphoid tissue chemokine (SLC) is a key CC chemokine for chemotaxis of immune cells and has been an attractive candidate for anti-tumor treatments. However, among the immune cells recruited by SLC to tumors, the CD25(+) Foxp3(+) regulatory T cells (Tregs) compromise the anti-t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chen, Long, Zhou, Shuang, Qin, Jie, Hu, Heng, Ma, Huiying, Liu, Binbin, Wang, Xuan, Ma, Jiaqi, Ye, Shenglong, Zhong, Cuiping, Zhou, Guomin, Liang, Chunmin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3914677/
https://ncbi.nlm.nih.gov/pubmed/24304581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-12-153
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados